2-naphthylamide has been researched along with angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrera-González, Mdel P; Dueñas, B; Martínez-Ferrol, J; Martínez-Martos, JM; Mayas, MD; Ramírez-Expósito, MJ | 1 |
1 trial(s) available for 2-naphthylamide and angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-
| Article | Year |
|---|---|
Neoadjuvant chemotherapy modifies serum angiotensinase activities in women with breast cancer.
Topics: Aminopeptidases; Angiotensin II; Anthracyclines; Antineoplastic Agents; Breast Neoplasms; Endopeptidases; Female; Glutamyl Aminopeptidase; Humans; Middle Aged; Naphthalenes; Neoadjuvant Therapy; Paclitaxel; Reference Values; Renin-Angiotensin System | 2012 |